TECH TRANSFER University Joins Industry. Maite Aguado Pharmaceutical Technology PL Synthon Hispania
|
|
- Hillary Sims
- 5 years ago
- Views:
Transcription
1 TECH TRANSFER University Joins Industry Maite Aguado Pharmaceutical Technology PL Synthon Hispania
2 About me.. - Chemical Degree (UAB) / Master In Pharmaceuticals and Related Products(IUCT) / Master In Project Management (La Salle)/Different trainings trough my professional experience - Working in Pharma industry for nearly 20 years: (IUCT/ Sanofi- Aventis/Combino Pharm/ Synthon) - Experience on Formulation Development, Scale up and Pilot Plant and Commercial processes. Date Tech Transfer - University Joins Industry 2
3 INDEX - What is Tech Transfer? - Tasks and Responsibilities - Background, key points and basic knowledge in - Technical Evaluation - Personal Skills - Career development Date Tech Transfer - University Joins Industry 3
4 What is Tech Transfer? Definition: is the process of transferring technology from the places and in groups of its origination to wider distribution among more people and places What does this means? üdeeply Knowledge of the Product and Process and Persons ütransfer of Knowledge to internal and external people ütransfer of processes: to internal and external plants Where does our responsibilities start? Tech Transfer R&D Development Scale up Pilot Plant Commercial Main Plant Prototype Trials Q batches S- batches Transfer Validation Commercial Date Tech Transfer - University Joins Industry 4
5 Tasks and Responsibilities First.understand with whom we are involved Maintenance QC QA Manufacturing Project Management Packaging Technology Suppliers TECH Group Supply Chain CMO Finnance Customers Purchase RA R&D Date Tech Transfer - University Joins Industry 5
6 And then. what are our tasks???? ØTransfers (New or already commercial): ümanufacturing Processes Transfer Launch: from the Pilot Plant to a Main Plant (Internal or external) Between Plants Scale up ü Packaging ØProcess Optimization: üreduce Costs, Times, Operational procedures üquality improvements o process variability ØTroubleshooting üsolve problems.as fast as you can!!!!!!! (Internal or External) üimprovements to avoid quality recurrences Date Tech Transfer - University Joins Industry 6
7 And then. what are our tasks???? Ø Others: üevaluation of manufacturing processes still on R&D phase ürevision of Submission Dossiers üinvestigate Deviations übe involve in Health Authorities and Customers Audits üevaluate new excipients or drug substance suppliers üevaluation of new CMO s, new equipments, new technologies ütechnical support in the regulatory submissions ütechnical support to Engineering, maintenance, QC,QA, manufacturing üevaluation of costs (validations, process costs..) üproduct Surveillance / Trend Analysis (continued process monitoring, APR s revision..) ütrainings We are the definitition of..multitasking!!!!!!!!!!!! Date Tech Transfer - University Joins Industry 7
8 Background, key points and basic knowledge Our maximum commandment: manufacturing products with the required quality. But always taking into account costs, time and flexibility. What we have to know to be excellent???? vthe product: Formulation: physical and chemical characteristics of excipients and drug substance; percentages, special requirements (sensible to the humidity/light..) Product development. Evaluation of the development in the R&D stages Final product specifications vthe process: Facilities Equipments: main equipments and auxiliary (ex. Pumps, tubs ) People!!!!!!!! Date Tech Transfer - University Joins Industry 8
9 Background, key points and basic knowledge vsubmitted dossiers What are the phases, equipments or settings approved? Type of product: standard, non standard Types of variation involved. What is needed to change the batch size, manufacturing site, equipment, settings. Countries????? vquality requirements: GMP, FDA, JPN????? vip patents. Can I change the excipient grade? Or change a setting or a manufacturing step? WE HAVE TO KNOW ALL ABOUT OUR PRODUCT, PROCESS,QUALITY, MARKET AND CLIENTS EXPECTATIONS. AND WITH ALL THIS INFORMATION WE PERFORM THE ASSESSMENT Date Tech Transfer - University Joins Industry 9
10 Technical Evaluation Once the previous evaluation is completed, the materials, process parameters and quality attributes are listed, categorized (critical or non critical) and related to each other. Materials Process Product (Critical) Material Attributes (Critical) Process Parameters (Critical) Quality Attributes Example: Granulation in a High Shear Mixer. Operation unit Materials Process parameters Quality attributes affected Granulation API Lactose Povidone Water Mixing Time Impeller speed Solution Addition time. Process time Dissolution/ Disintegration Uniformity of dosage units Assay Date Tech Transfer - University Joins Industry 10
11 Technical Evaluation According to the previous study, the risks are categorized and the mitigation actions are planned. Operation Unit Granulation CPP Risk CQA affected Mitigation Risk Mixing Time and speed High Assay Blend Uniformity Granulate Addition Medium Dissolution Disintegration Control of Torque Date Tech Transfer - University Joins Industry 11
12 Technical Evaluation When all the manufacturing steps, attributes and materials have been evaluated then.we evaluate the type of final study that we need: ØWe need to perform Trials for a better evaluation? For example when we have to transfer a manufacturing process between sites but we have non similar equipments ØQualification batch. We buy a new machine but it is equal to the previous used for the manufacturing and the risk is low. We made only one batch. ØValidation. Changes with high impact. For example. Transfers between sites, batch size increase. Than we have to chose the type of validation and how many batches are involved. ütraditional process validation: batches, complete validation ücontinuous process verification: CQAs and CPPs (when the R&D applies Quality by Design) ühybrid approach Traditional validation+ Continuous Process Verification Date Tech Transfer - University Joins Industry 12
13 Skills - Degree in Life Sciences - English But Also.. - Optimistic, curious, able to learn everyday - Multi-task, capable to work under pressure - Pragmatism - Resilient - Capable of making decisions - Open minded, emphatic - Work in group - Like to travel Date Tech Transfer - University Joins Industry 13
14 Career Development Manufacturing Quality Assurance TECH R&D Project Management Date Tech Transfer - University Joins Industry 14
15 Questions? THANKS FOR YOUR ATTENTION!!! Date Tech Transfer - University Joins Industry 15
Q8 and Q8 annex An industry Perspective
Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference
More informationQuality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development
Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com
More informationAnalytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective
Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Dr. Øyvind Holte Norwegian Medicines Agency EMA PAT team/ EDQM PAT working party 15 October, 2014, Heidelberg
More informationPMDA perspective on Quality by Design for pharmaceutical products
PMDA perspective on Quality by Design for pharmaceutical products Junichi Fukuchi, Ph.D. Office of Cellular and Tissue-based Products Pharmaceuticals and Medical Devices Agency (PMDA) Annual conference
More informationImplementation of ICH Q8 and QbD An FDA Perspective
ISPE, Yokohama, Japan June 9, 2006 Implementation of ICH Q8 and QbD An FDA Perspective Chi-wan Chen, Ph.D. Office of New Drug Quality Assessment Center for Drug Evaluation and Research Food and Drug Administration
More informationChallenges of Implementation of ICH Q 8
Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated
More informationValue Paper. Are you PAT and QbD Ready? Get up to speed
Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more
More informationEU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationImportance of ICH Guidance in Fulfilling Process Validation Requirements
Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process
More informationLeader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
More informationCMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.
CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) MFDS Nov 11, 2016 1 Agenda Introduction of PMDA ICH Q12 QbD assessment
More informationApplication of Visible-Residue Limit for Cleaning Validation Richard J. Forsyth and Vincent Van Nostrand By Richard J. Forsyth,Vincent Van Nostrand
October 2, 2005 Application of Visible-Residue Limit for Cleaning Validation Richard J. Forsyth and Vincent Van Nostrand By Richard J. Forsyth,Vincent Van Nostrand Pharmaceutical plants must have visually
More informationJUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
More informationSTRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN
STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN CHRISTOPHER J POTTER ISPE ADVISOR AND CMC CONSULTANT 1 AGENDA Background ICH Guidelines Terms and Definitions Supporting Information ISPE publications
More informationPROCESS ANALYTICAL TECHNOLOGY (PAT) - AS A CULTURE OF INNOVATION
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.4, pp 1339-1344, Oct-Dec 2009 PROCESS ANALYTICAL TECHNOLOGY (PAT) - AS A CULTURE OF INNOVATION Deepak D. Pokharkar*,
More informationImplementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
More informationGlobal GMP Harmonisation A Japanese Perspective
Global GMP Harmonisation A Japanese Perspective Yukio Hiyama, Ph.D. Chief, Third Section, Division of Drugs, National Institute of Health Sciences, The Ministry of Health Labour and Welfare, JAPAN ISPE
More informationEDQM Conference. Quality of Medicines in a Globalised World: Dreams and Reality
EDQM Conference Quality of Medicines in a Globalised World: Dreams and Reality 14-15 October 2010 Prague, Czech Republic 2010 EDQM, Council of Europe, All rights reserved Plenary Session Dr Moheb M. Nasr
More informationTechnology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems
Technology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems A robust and secure manufactured product is the desired end result for pharmaceutical companies. Scale-up and
More informationFrom API to Formulated Product
From API to Formulated Product Jean-Marie Geoffroy, PhD Director, Product Development Takeda Global Research & Development 675 N Field Drive Lake Forest, IL 60045 jean-marie.geoffroy@tgrd.com Acknowledgments
More informationFeedback EMEA / Industry Discussion
Feedback EMEA / Industry Discussion Eli Lilly & Co Ltd Case Study: Use of In-Line Near-Infrared Spectroscopy to Monitor Segregation of a Pharmaceutical Powder Blend in a Tablet Press Martin Diller PhD,
More informationQuality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
More informationTimescales for Change A Look at Innovation in the Pharmaceutical Industry
Timescales for Change A Look at Innovation in the Pharmaceutical Industry 3rd FDA/PQRI Conference on Advancing Product Quality 23 Mar 2017 Robert F. Meyer, Ph.D. Global Pharmaceutical Commercialization
More informationMAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals
MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A
More informationPharmaceutical Manufacturing and Engineering Catalog Excerpt
Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical
More informationGlatt Technology Center
Glatt Technology Center Pharmaceutical Development Formulation Development Process Development Scale-Up Contract Manufacturing Equipment Design Technology Transfer Full Service Development. Scale-Up. Production.
More informationAPIs global business developments
APIs global business developments Dr Gian Mario Baccalini EFCG Board Member, Chairman of EFCG Pharma Business Committee President & CEO, Euticals S.p.A., Italy EFCG Press Conference, 13th October 2015,
More informationQuality by Design and OINDP. Today s Presentation
Quality by Design and OINDP Setting the Stage John C Berridge IPAC-RS September 2008 Today s Presentation QbD definition Setting the stage from an ICH perspective Future Opportunities 2 QbD Definition
More informationICH Q8 / ICH Q11 Training Course
ICH Q8 / ICH Q11 Training Course From QbD to Process Validation Speakers: Dr Thomas Hille LTS Lohmann Therapie- Systeme AG Dr Øyvind Holte Norwegian Medicines Agency, EDQM PAT working party/ EMA PAT team
More informationAPI hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.
API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our
More informationPharmaceutical Process Development
Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage
More informationSection heading. Strapline sub-heading
Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide
More informationTerrence Tougas. Dennis Sandell
Terrence Tougas Boehringer Ingeheim, Ridgefield, CT Dennis Sandell S5 Consulting, Lund, Sweden (c) 2011 Sandell & Tougas 1 Transforming the general concept of Quality into objective, well defined and actionable
More informationInternational Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT
Research Article Analytical Chemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY SARAVANA KUMAR.V
More informationEmbracing Quality by Design. Applying QbD concepts can help CMOs create value
Embracing Quality by Design Applying QbD concepts can help CMOs create value By Russ Somma, Ph.D. and Andrew A. Signore, PE, PMP-DBIA, CPIP SommaTech, LLC Integrated Project Services (IPS) THE PHARMACEUTICAL
More informationInnovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series
CAMO European Pharmaceutical Seminars Jan/Feb 2009 Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series The Increasing Need of Multivariate Analysis for Process Understanding
More informationFuture of Pharmaceutical Quality and the Path to Get There
Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,
More informationQbD/PAT Implementation: The Road to RTR From Science to Compliance
Quality by Design China 2013 April 17-18, 2013 Shanghai, China Pedro Hernandez, PhD 何盼多博士 Senior Director Quality Assurance - China http://www.frontagelab.com pedrohernandez@frontagelab.com.cn Background
More informationConsiGma TM, a platform for continuous processing
ConsiGma TM, a platform for continuous processing GEA Pharma Systems Where Inspiration meets Technology GEA Process Engineering / GEA Pharma Systems ConsiGma TM R&D and Manufacturing platform ConsiGma
More informationICH Q8, 9 & 10 and the Impact on the QP
1 ICH Q8, 9 & 10 and the Impact on the QP Peter H. Gough David Begg Associates phg@david-begg-associates.com 2 A New Approach to Regulation Approach to the regulation of pharmaceuticals is undergoing a
More informationThe Changing Face of Product and Process Development in the QbD Era. James Kraunsoe AstraZeneca Product Development UK/US
The Changing Face of Product and Process Development in the QbD Era James Kraunsoe AstraZeneca Product Development UK/US Disclaimer The views and opinions expressed in the following PowerPoint slides are
More informationProcess Analytical Technology (PAT): A Real Time Quality Assurance
Review Article Process Analytical Technology (PAT): A Real Time Quality Assurance Punita Raj, N. Vishal Gupta* Pharmaceutical Quality Assurance group, JSS College of Pharmacy, JSS University, Sri Shivarathreeshwara
More informationHow Process Models can Facilitate Quality Risk Management for Emerging Technologies
How Process Models can Facilitate Quality Risk Management for Emerging Technologies Thomas O Connor, Ph.D. FDA-AIChE Workshop on Adopting Continuous Manufacturing North Bethesda, MD March 2 th, 2016 2
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationQbD Application in Japan: PMDA Perspective
CMC Strategy Forum Japan 2013 Hotel Okura, Tokyo, Japan, December 9 10, 2013 QbD Application in Japan: PMDA Perspective Yasuhiro Kishioka, PhD. Reviewer Office of Cellular and Tissue based Products Pharmaceuticals
More informationArtwork Lifecycle Process Management. Vilva Natarajan CEO, Karomi
Artwork Lifecycle Process Management Vilva Natarajan CEO, Karomi Which Artworks? Labels Cartons PIL Pack Inserts PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Section in the SPL Mock Artwork for Submission Commercial
More informationWHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.
WHITE PAPER FACILITY FOCUS: GMP Facility Modernization By: David M. Marks, P.E. July 2017 Introduction In recent years, intensified industry competition and cost pressures have renewed interest in modernizing
More informationSymposium on Continuous Manufacturing of Pharmaceuticals Notes
1 2012 11 13 Symposium on Continuous Manufacturing of Pharmaceuticals Notes These are notes from the first open meeting regarding Novartis- MIT Center for Continuous Manufacturing (CCM). The meeting is
More informationVisioNIR. High Speed NIR Spectrometer for 100% Process Inspection
VisioNIR High Speed NIR Spectrometer for 100% Process Inspection Table of Content Introduction... 2 visiotec VisioNIR High Speed NIR Spectrometer: Your Way to PAT... 2 The benefits of the VisioNIR system...
More informationGlatt Technology Center
Glatt Technology Center Pharmaceutical Development Formulation Development Process Development Scale-Up Contract Manufacturing Equipment Design Technology Transfer We set the standards Contract manufacturing
More informationThe GEA Pharma Solids Center. Improving your products, optimizing your processes, making science work
The GEA Pharma Solids Center Improving your products, optimizing your processes, making science work 2 GEA PHARMA SOLIDS CENTER COMMITTED TO OUR CUSTOMERS With our unparalleled history of expertise in
More informationICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective
14 th DIA Japan Annual Meeting 2017 November 12-14, 2017 Tokyo Big Sight Ariake ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective Yasuhiro Kishioka, Ph.D. Principal Reviewer Office
More informationTechnical Specifications: Supply of Seamless Grade TP304L Pipe and Grade WP304L Pipework Fittings to the ITER Organization (IO).
IDM UID: R22L3M ver 1.4 Technical Specifications: Supply of Seamless Grade TP304L Pipe and Grade WP304L Pipework Fittings to the ITER Organization (IO). Contents 1 Terms and Acronyms... 3 2 Background...
More informationQUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS
VICH GL 45 (QUALITY) BRACKETING AND MATRIXING April 2010 For Implementation at Step 7 QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS
More informationQuality Regulation under Revised Pharmaceutical Affair Law
Quality Regulation under Revised Pharmaceutical Affair Law Yukio Hiyama, Ph.D. Division of Drugs, National Institute of Health Sciences, the Ministry of Health, Labour and Welfare, Japan E mail hiyama@nihs.go.jp
More information2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
More informationClaudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group
FDA Compliance and Regulatory Symposium Understanding the FDA s Latest cgmp Guidances: Opportunities and Pitfalls Claudio Pincus, President, The Group R. Owen Richards, President, Regulatory Services Daniel
More informationQuality Risk Management
Quality Risk Management Iron Chef Edition Keith D. Gibbs kage and sui generis Ninja Project Management My story shapes my perspective Bachelor of Science work in Earth Science with focus on Hydrogeology.
More informationTechnically Unavoidable Particles Profile (TUPPs) Guide
Technically Unavoidable Particles Profile (TUPPs) Guide Priscilla Zawislak Global Regulatory Affairs Manager Ashland Inc. Chair Elect, IPEC-Americas pszawislak@ashland.com www.ipecamericas.org 1 Agenda
More informationIntroduction. Methods: Spherical Granulation. Shawn Engels, Vector Corporation
DISCUSSION OF PROCESSES WHICH UTILIZE CONICAL ROTOR TECHNOLOGY (SPHERONIZATION OR SPHERICAL GRANULATION, POWDER LAYERING OF ACTIVES OR POLYMERS, CONVENTIONAL SOLUTION/SUSPENSION APPLICATION OF ACTIVES
More informationCDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
More informationTechnology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer as a Process Strategy
Journal of Pharmacy and Pharmacology 5 (2017) 299-313 doi: 10.17265/2328-2150/2017.06.002 D DAVID PUBLISHING Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer
More informationCombination Products Verification, Validation & Human Factors Sept. 12, 2017
Combination Products Verification, Validation & Human Factors Sept. 12, 2017 Speaker Scott Thiel Director, Navigant Consulting Regulatory consulting in Life Sciences industry with focus on medical devices,
More informationCLICK TO ADD TITLE [SPEAKERS NAMES]
CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors 10th Global Health Supply Chain Summit, Accra (Ghana); Nov 15-17, 2017 Pharmaceutical Manufacturing in Ghana Challenges and Potential
More informationInternational Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA
International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical
More informationBosch Packaging Academy Seminars & Workshops
Bosch Packaging Academy Seminars & Workshops 2018 www.boschpackaging.com/academy All Bosch Packaging Academy Seminars & Workshops at a glance The Bosch Packaging Academy team is proud to present the new
More informationIntroduction to STP (Clinical Science) Clinical Pharmaceutical Sciences
Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching
More informationHow CDER is Encouraging Adoption of Emerging Technologies in Pharmaceutical Industry
How CDER is Encouraging Adoption of Emerging Technologies in Pharmaceutical Industry Moderator: Lawrence Yu Speakers: Thomas O Connor & Sharmista Chatterjee Emerging Technology: A Key Enabler for Modernizing
More informationICH Q10 Pharmaceutical Quality System
Safeguarding public health ICH Q10 Pharmaceutical Quality System An EU Regulator s Perspective Presentation overview Why does Q10 exist and what were the desired outcomes Content of the Q10 step 2 document
More informationDSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals 140 years of innovation February 2015 Cover photo: daisy in gras, istock Safe Harbor Statement Although diligent care has been used to ensure that the information provided
More informationBrazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma
Brazilian industry s activities for international convergence Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Mission Congregate companies, institutes and association
More informationTraining. Education CALENDAR FEDEGARI TECH CENTERS DM#407036
2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop
More informationManufacture of medicinal products in Italy: challenges for the Italian Medicines Agency
Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency Isabella Marta Coordinator Inspections and Certification Dept. Head Manufacturing Authorization Office Italian Medicines
More informationWorkshop: GRANULATION & TABLETING New requirements for an established technology - robustness, efficiency and quality.
Workshop: GRANULATION & TABLETING New requirements for an established technology - robustness, efficiency and quality. 12 14 April 2016 WHY PARTICIPATE? This workshop on granulation and tableting is a
More informationClaus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team
Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team
More informationWHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future. By: Hite Baker
WHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future By: Hite Baker August 2017 Introduction This Facility Focus Survey Report explores how to design sterile
More informationTechnology transfer in pharmaceutical industry- A Review
Popat B. Mohite and Sachin V. Sangle / International Journal of Advances in Pharmaceutics 2017; 06(01): 01-07. 1 International Journal of Advances in Pharmaceutics E-ISSN: 2320-4923; P-ISSN: 2320-4931
More informationPresentation. March 2007
Presentation March 2007 1 Corporate Overview 2 Corporate Overview Leading provider of research-driven packaging solutions solely-focused on pharmaceutical industry Founded in 1994 and based in Pune, India
More informationImpact of ICH Q9 and the application of Risk Management
Safeguarding public health Impact of ICH Q9 and the application of Risk Management An inspector s perspective on the impact on inspectional approaches and expectations Ian Thrussell Strategy and Development
More informationEXCIPIENTS KNOWLEDGE MANAGEMENT: CHALLENGES & SOLUTIONS
IFPAC Annual Meeting, Jan. 24 - Jan. 27, 2016. Arlington, VA, U.S.A 1 EXCIPIENTS KNOWLEDGE MANAGEMENT: CHALLENGES & SOLUTIONS AJAZ S. HUSSAIN, PH.D., THE NATIONAL INSTITUTE OF PHARMACEUTICAL TECHNOLOGY
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationMicrocrystalline Wax and Wax Blends. Absolute Purity.
Microcrystalline Wax and Wax Blends. Absolute Purity. Sonneborn microcrystalline waxes and wax blends. A full spectrum of absolute purity. Sonneborn s line of Multiwax and wax blends brings optimum quality
More informationQuality assurance in the supply chain for pharmaceuticals from the WHO perspective
1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation
More informationPharmaceutical Products and Services
Pharmaceutical Products and Services Johnson Matthey (JM) combines specialist expertise and a 200-year heritage, to deliver a collaborative service offering focused on strengthening your products to ensure
More informationWorld Journal of Pharmaceutical Research SJIF Impact Factor 7.523
SJIF Impact Factor 7.523 Volume 6, Issue 9, 310-329. Review Article ISSN 2277 7105 THE IMPORTANT ROLE OF TECHNOLOGY TRANSFER IN PHARMACEUTICAL INDUSTRY-A REVIEW Yogesh S. Waghmare* and Sonali P. Mahaparale
More informationSectoral Patterns of Technical Change
Sectoral Patterns of Technical Change Chapter 7, Miozzo, M. & Walsh, V., International Competitiveness and Technological Change, Oxford University Press. Overview Introduction Why should we classify sectoral
More informationTechnology to meet the needs of patients around the world
Technology to meet the needs of patients around the world Dr. Michael Thien, Senior Vice President Global Science, Technology and Commercialization Merck & Co., Inc. Our Past Scientific approach applied
More informationSpeed Innovation Happiness. Corporate Overview
Corporate Overview Contents Bilcare Overview Businesses Business Strategy Financial Overview 2 Bilcare Overview 3 Bilcare Overview Our Objective Vision Delivering Innovation Transforming Lives Values Speed
More informationGranulation & Tableting
Granulation & Tableting GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms Solving sticking, capping & lamination problems SPEAKERS: Dr Michael Braun Boehringer Ingelheim Pharma,
More informationLeveraging Med Device Expertise to Develop Combination Products
Leveraging Med Device Expertise to Develop Combination Products 20 th Annual Drug Delivery Partnership Conference January 20, 2016 Dirk Smith VP of Technology Solutions Minnetronix, Inc. 250 employees,
More informationMaster Data Management: Building readiness for regulations Compliance can benefit, but so can internal speed and efficiency
Master Data Management: Building readiness for regulations Compliance can benefit, but so can internal speed and efficiency What s at stake? As part of their obligation to communicate accurate and changing
More informationFactors that should be considered when selecting and sizing a mixer are:
Mixer Performance Mixing Equipment Factors that should be considered when selecting and sizing a mixer are: Production capacity requirements The bulk density of the mixed feed The amount of liquids to
More informationSubmission of comments on Review of the Variations Guidelines (EC 1234/2008)
12 July 2012 Submission of comments on Review of the Variations Guidelines (EC 1234/2008) Comments from: Name of organisation or individual Leem Please note that these comments and the identity of the
More informationHow to take advantage of China knowledge base?
How to take advantage of China knowledge base? A CEIBS-SKEMA joint research project Barcelona, November 2013. 02/12/2013 1 A changing landscape A new world order in innovation is taking hold, one in which
More informationInnovative technologies for powder processing
Innovative technologies for powder processing Our Values Passion Competence Innovation Sustainability The company Foundation 1985, turbulent times socially, economically, politically, musically, and electronically!
More informationTOP INDUSTRY EXPERTS IN ONE TRAINING EVENT!
TOP INDUSTRY EXPERTS IN ONE TRAINING EVENT! Join Natoli and the foremost subject matter experts for a unique hands-on training and troubleshooting panel discussion TONY CARPANZANO FORMULATION STUART PORTER
More informationISPE India in collaboration with
ISPE India in collaboration with Glatt India Engineering Pvt. Ltd. IPS Mehtalia Private Limited Jacobs NNE Powder Systems Group Steris Life Sciences Presents a conference on Current Trends and Development
More informationICH Q7 - API. Presented by Ashley Isbel 4 July, 2016
ICH Q7 - API Presented by Ashley Isbel 4 July, 2016 ICH Q7 ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (November 2000) Adopted or referenced by: PIC/S in 2007 - Guide
More informationCORE EXPERTISE IN YOUR TECHNOLOGIES
CORE EXPERTISE IN YOUR TECHNOLOGIES MERSEN INSIDE MERSEN INSIDE MERSEN INSIDE MERSEN INSIDE CORPORATE PROFILE Global expert in electrical power and advanced materials, Mersen designs innovative solutions
More information